Prediabetes and cardiovascular risk in hypertensive patients Julian SeguraCecilia RoldänLuis M. Ruilope Editor’s Commentary Pages: 97 - 100
Should we employ combination ACEI and ARB therapy in primary hypertension? Robert M. Carey Invited Commentary Pages: 101 - 102
Uric acid and hypertension Daniel I. FeigDuk-Hee KangRichard J. Johnson OriginalPaper Pages: 111 - 115
Uric acid: Its relationship to renal hemodynamics and the renal renin-angiotensin system Xiaoyan ZhouLuis MatavelliEdward D. Frohlich OriginalPaper Pages: 120 - 124
Nonmodulation and essential hypertension Norman K. HollenbergGordon H. Williams OriginalPaper Pages: 127 - 131
The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy Raghu V. DurvasulaStuart J. Shankland OriginalPaper Pages: 132 - 138
Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease Jiawei ChenJawahar L. Mehta OriginalPaper Pages: 139 - 143
Hyperfiltration, nitric oxide, and diabetic nephropathy David Z. Levine OriginalPaper Pages: 153 - 157
Sodium transporters in the distal nephron and disease implications Carolyn A. EcelbargerSwasti Tiwari OriginalPaper Pages: 158 - 165
Pathogenesis of salt sensitivity of blood pressure Myron H. Weinberger OriginalPaper Pages: 166 - 170
Development of microalbuminuria in essential hypertension Josep RedonJose M. Pascual OriginalPaper Pages: 171 - 177
